Johnson & Johnson (JNJ)
$145.91
3.07 (2.06%)
JNJ Stock Quote Delayed 15 Minutes
Previous Close
$145.91
Market Cap
391.35B
PE Ratio
317.20
EPS
0.46
Volume (Avg. Vol.)
10.59M
Day's Range
145.25 - 149.00
52-Week Range
126.10 - 154.50
Dividend & Yield
3.48 (2.39%)
JNJ Stock Predictions, Articles, and Johnson & Johnson News
Can JNJ Stock Keep on Its Current Growth Track?
Although JNJ stock has legal concerns that weigh on the narrative, the important point is to have the right focus; by that, I mean its stable dividends.
Why Johnson & Johnson Is Deceptively Boring
JNJ stock is on a scorching run in the markets recently, but the underlying fundamentals suggest that shares are close to fully pricing in the optimism.
Johnson & Johnson Stock Looks Like a Safe Place to Hide Out
JNJ stock has rallied as legal worries recede. Even at highs, J&J stock looks like an attractive pick for defensive-minded investors.
How Disease Outbreaks Affect Stock Prices
While each is different, we can look to historical disease outbreaks to predict the impact of China's coronavirus on today's markets.
Did Investors Miss Their Chance with Shopify Stock?
Shopify stock has been on fire, leading the growth industry higher and higher. When it pulls back, will investors still consider it a buy?
Stock Market Today: Beyond Meat Grows Partnerships; Coronavirus Cure?
Talks about a coronavirus cure and Beyond Meat's expanding partnership were key talking points in the stock market today.
Stock Market Today: Apple’s New iPhone; Tesla at $100 Billion
J&J, IBM and Netflix were a focus in the stock market today, as they reported earnings. Tesla tops $100 billion, too.
Johnson & Johnson Earnings: JNJ Stock Ticks Lower on Q4 Results
Johnson & Johnson (JNJ) earnings for the medical device and consumer goods company's fourth quarter of 2019 have JNJ stock down on Wednesday.
Johnson & Johnson Stock Will Continue To Rally Into 2020
Higher R&D spending and global expansion will support JNJ stock growth, driven by Johnson & Johnson's pharmaceutical segment.
Should Investors Buy Johnson & Johnson Stock Prior to Earnings?
Although the pharma giant will likely continue to grow in 2020, Johnson & Johnson stock may be volatile due to litigation risk.
Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability
JNJ reported strong Q3 results and its business outlook is positive. But Johnson & Johnson stock is likely to be hurt by legal liabilities.
Dow Jones Today: Stocks Continue Building Momentum
Stocks continue trending higher and the data points out Tuesday were very strong, indicating a Santa Claus rally could be afoot.
Stock Market Today: Roku’s CFO Stepping Down; Buy Microsoft?
Roku shares fall as its CFO resigns. Here's what else happened in the stock market today, as bulls search for new highs.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
